INTRADUCTAL PROLIFERATIVE BREAST LESION

This adverse event was reported 1252 times

These drugs are most commonly taken by patients reporting INTRADUCTAL PROLIFERATIVE BREAST LESION:

# Drug Count
0 ERGOCALCIFEROL 106
1 ADALIMUMAB 98
2 METHOTREXATE SODIUM 95
3 NATALIZUMAB 90
4 METHOTREXATE 84
5 LENALIDOMIDE 78
6 INTERFERON BETA-1A 67
7 ETANERCEPT 59
8 OMEPRAZOLE MAGNESIUM 52
9 FOLIC ACID 49
See all common drugs associated with INTRADUCTAL PROLIFERATIVE BREAST LESION

INTRADUCTAL PROLIFERATIVE BREAST LESION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ERGOCALCIFEROL 106 0.0036
1 ALENDRONATE SODIUM AND CHOLECALCIFEROL 8 0.0029
2 ANASTROZOLE TABLETS 28 0.0013
3 ANASTROZOLE 34 0.0009
4 GOLIMUMAB 11 0.0009
5 PERTUZUMAB 21 0.0008
6 TESTOSTERONE 14 0.0006
7 DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE 8 0.0006
8 FINGOLIMOD HCL 45 0.0005
9 ALEMTUZUMAB 10 0.0005
See all drugs enriched for association with INTRADUCTAL PROLIFERATIVE BREAST LESION